You searched for "modelling"
Coventry Community Eye Hospital recognised as ‘Outstanding’
Care and Quality Commission awards CHEC highest possible rating.Glaucoma UK ‘Excellence in Glaucoma Care Award 2024’ Winner Announcement
PhD student at Glasgow Caledonian University wins the Glaucoma UK ‘Excellence in Glaucoma Care Award 2024’.
Cost-effectiveness of orthoptic-delivered screening versus school nurse screening
The authors describe a long-term audit of outcomes and costs associated with referrals from two established neighbouring school-entry vision screening services in the UK over one academic year with one adhering to national UK screening guidelines more closely than the...My Top Five: Promising gene therapies for ocular conditions
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...My Top Five: Promising gene therapies for ocular conditions
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...The madarosis mystery: unravelling the clues to a host of health issues
Eyelash madarosis is a medical condition characterised by the loss of eyelashes caused by the destruction of hair follicles. It can range from a few missing lashes to a complete absence of lashes on the eyelids. This condition can be...Andy Hill (NuVision Biotherapies) discusses recent AOP update to clinical guidelines
There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.SCONe Project seeks participants for patient and public involvement group to revolutionise AMD research
The SCONe project, run by optometrists, ophthalmologists, and researchers from the University of Edinburgh, and funded by Sight Scotland, is appealing for participants to take part in a Patient and Public Involvement (PPI) group focused on revolutionising the detection and management of Age-Related Macular Degeneration (AMD).
